This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maiti, K. Articles by Seong, J. Y. Search for Related Content PubMed PubMed Citation Articles by Maiti, K. Articles by Seong, J. Y. Related Collections Endocrine Oncology Male Endocrinology

Differential Effects of Gonadotropin-Releasing Hormone (GnRH)-I and GnRH-II on Prostate Cancer Cell Signaling and Death

Hormone Research Center (K.M., D.Y.O., J.S.M., S.A., J.H.L., D.G.B., H.-S.P., K.L., Y.C.L., H.B.K., J.Y.S.) and School of Biological Sciences and Technology, Chonnam National University, Gwangju 500-757, Republic of Korea; Neurogenex Co. Ltd. (N.C.J.), Biotechnology Incubating Center Golden Helix, Seoul National University, Seoul 151-744, Republic of Korea; School of Biological Sciences (K.K.), Seoul National University, Seoul 151-742, Republic of Korea; Institut National de la Santé et de la Recherche Médicale U413, Laboratory of Cellular and Molecular Neuroendocrinology (H.V.), European Institute for Peptide Research, University of Rouen, 76821 Mont-Saint-Aignan, France; and Laboratory of G Protein Coupled Receptors (J.Y.S.), Korea University College of Medicine, Seoul 136-705, Republic of Korea

Address all correspondence and requests for reprints to: Jae Young Seong, Ph.D., Laboratory of G Protein Coupled Receptors, Korea University College of Medicine, Seoul 136-705, Republic of Korea. E-mail: jyseong{at}korea.ac.kr; or Hyuk Bang Kwon, Ph.D., Hormone Research Center and School of Biological Sciences and Technology, Chonnam National University, Gwangju 500-757, Republic of Korea. E-mail: kwnohb{at}chonnam.ac.kr.

Context: GnRH is known to directly regulate prostate cancer cell proliferation, but the precise mechanism of action of the peptide is still under investigation.

Objective: This study demonstrates differential effects of GnRH-I and GnRH-II on androgen-independent human prostate cancer cells.

Results: Both GnRH-I and GnRH-II increased the intracellular Ca²⁺ concentration ([Ca²⁺]_i) either through Ca²⁺ influx from external Ca²⁺ source or via mobilization of Ca²⁺ from internal Ca²⁺ stores. Interestingly, the [Ca²⁺]_i increase was mediated by activation of the ryanodine receptor but not the inositol trisphosphate receptor. Trptorelix-1, a novel GnRH-II antagonist but not cetrorelix, a classical GnRH-I antagonist, completely inhibited the GnRH-II-induced [Ca²⁺]_i increase. Concurrently at high concentrations, trptorelix-1 and cetrorelix inhibited GnRH-I-induced [Ca²⁺]_i increase, whereas at low concentrations they exerted an agonistic action, inducing Ca²⁺ influx. High concentrations of trptorelix-1 but not cetrorelix-induced prostate cancer cell death, probably through an apoptotic process. Using photoaffinity labeling with ¹²⁵I-[azidobenzoyl-D-Lys⁶]GnRH-II, we observed that an 80-kDa protein specifically bound to GnRH-II.

Conclusions: This study suggests the existence of a novel GnRH-II binding protein, in addition to a conventional GnRH-I receptor, in prostate cancer cells. These data may facilitate the development of innovatory therapeutic drugs for the treatment of prostate cancer.

This article has been cited by other articles:

				J. Liu, C. D. MacCalman, Y.-l. Wang, and P. C. K. Leung Promotion of Human Trophoblasts Invasion by Gonadotropin-Releasing Hormone (GnRH) I and GnRH II via Distinct Signaling Pathways Mol. Endocrinol., July 1, 2009; 23(7): 1014 - 1021. [Abstract] [Full Text] [PDF]

				M. Montagnani Marelli, R. M. Moretti, S. Mai, J. Januszkiewicz-Caulier, M. Motta, and P. Limonta Type I Gonadotropin-Releasing Hormone Receptor Mediates the Antiproliferative Effects of GnRH-II on Prostate Cancer Cells J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1761 - 1767. [Abstract] [Full Text] [PDF]

				D.-K. Kim, J. S. Yang, K. Maiti, J.-I. Hwang, K. Kim, D. Seen, Y. Ahn, C. Lee, B.-C. Kang, H. B. Kwon, et al. A Gonadotropin-Releasing Hormone-II Antagonist Induces Autophagy of Prostate Cancer Cells Cancer Res., February 1, 2009; 69(3): 923 - 931. [Abstract] [Full Text] [PDF]

				S Darby, J Stockley, M M Khan, C N Robson, H Y Leung, and V J Gnanapragasam Expression of GnRH type II is regulated by the androgen receptor in prostate cancer Endocr. Relat. Cancer, September 1, 2007; 14(3): 613 - 624. [Abstract] [Full Text] [PDF]

				S. Fister, A. R. Gunthert, G. Emons, and C. Grundker Gonadotropin-Releasing Hormone Type II Antagonists Induce Apoptotic Cell Death in Human Endometrial and Ovarian Cancer Cells In vitro and In vivo Cancer Res., February 15, 2007; 67(4): 1750 - 1756. [Abstract] [Full Text] [PDF]